• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Medison buys EchoCath ColorMark devices

Article

EchoCath of Princeton, NJ, has shipped 50 of its ColorMark needle-biopsy guidance systems to Korean ultrasound vendor Medison. EchoCath said the shipment is the first international delivery of ColorMark, and the company expects to send more ColorMark

EchoCath of Princeton, NJ, has shipped 50 of its ColorMark needle-biopsy guidance systems to Korean ultrasound vendor Medison. EchoCath said the shipment is the first international delivery of ColorMark, and the company expects to send more ColorMark units to Medison in the next year.

ColorMark consists of a driver box that sends minute vibrations through a disposable clip into a biopsy needle, causing the needle to show up as a stripe of color on color Doppler scans (SCAN 5/19/93). EchoCath believes the system can improve visualization during biopsy procedures, such as breast biopsy exams.

In other EchoCath news, the company this month reported revenues for its second quarter (end-February) of $150,000, compared with no revenues in the same period a year ago, before the company had started actively marketing products. EchoCath's net loss for the quarter was $663,000, compared with a net loss of $1.2 million in the second quarter of 1996.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.